Agglomerates of aberrant DNA methylation are associated with toxicant-induced malignant transformation

Epigenetics

Volumn 7, Issue 11, 2012, Pages 1238-1248

  Severson, Paul L ^a   Tokar, Erik J ^b   Vrba, Lukas ^c,d   Waalkes, Michael P ^b   Futscher, Bernard W ^a,c  

^a UNIVERSITY OF ARIZONA   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d INSTITUTE OF PLANT MOLECULAR BIOLOGY   (Czech Republic)

Author keywords

Agglomerative DNA methylation; Arsenic; Cadmium; DNA methylation; Epigenetics; H3K27me3; H3K9me3; Long range epigenetic silencing; Malignant transformation

Indexed keywords

EID: 84868349976     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.22163     Document Type: Article

References (60)

1. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Some drinking-water disinfectants and contaminants, including arsenic. IARC Monogr Eval Carcinog Risks Hum 2004. 84:1-477. PMID:15645577.
2. Chen Y, Graziano JH, Parvez F, Liu M, Slavkovich V, Kalra T, et al. Arsenic exposure from drinking water and mortality from cardiovascular disease in Bangladesh: prospective cohort study. BMJ 2011. 342:d2431. PMID:21546419. http://dx.doi.org/10.1136/bmj.d2431.
3. Vahter M. Health effects of early life exposure to arsenic. Basic Clin Pharmacol Toxicol 2008. 102:204-211. PMID:18226075. http://dx.doi.org/10.1111/j.1742-7843.2007.00168.x.
4. Huff J, Lunn RM, Waalkes MP, Tomatis L, Infante PF. Cadmium-induced cancers in animals and in humans. Int J Occup Environ Health 2007. 13:202-212. PMID:17718178.
5. Sens DA, Park S, Gurel V, Sens MA, Garrett SH, Somji S. Inorganic cadmium- and arsenite-induced malignant transformation of human bladder urothelial cells. Toxicol Sci 2004. 79:56-63. PMID:14976345. http://dx.doi.org/10.1093/toxsci/kfh086.
6. Achanzar WE, Brambila EM, Diwan BA, Webber MM, Waalkes MP. Inorganic arsenite-induced malignant transformation of human prostate epithelial cells. J Natl Cancer Inst 2002. 94:1888-1891. PMID:12488483. http://dx.doi.org/10.1093/jnci/94.24.1888.
7. Wang Z, Zhao Y, Smith E, Goodall GJ, Drew PA, Brabletz T, et al. Reversal and prevention of arsenicinduced human bronchial epithelial cell malignant transformation by microRNA-200b. Toxicol Sci 2011. 121:110-122. PMID:21292642. http://dx.doi.org/10.1093/toxsci/kfr029.
8. Achanzar WE, Diwan BA, Liu J, Quader ST, Webber MM, Waalkes MP. Cadmium-induced malignant transformation of human prostate epithelial cells. Cancer Res 2001. 61:455-458. PMID:11212230.
9. Ren X, McHale CM, Skibola CF, Smith AH, Smith MT, Zhang L. An emerging role for epigenetic dysregulation in arsenic toxicity and carcinogenesis. Environ Health Perspect 2011. 119:11-19. PMID:20682481. http://dx.doi.org/10.1289/ehp.1002114.
10. Hou L, Zhang X, Wang D, Baccarelli A. Environmental chemical exposures and human epigenetics. Int J Epidemiol 2012. 41:79-105. PMID:22253299. http://dx.doi.org/10.1093/ije/dyr154.
11. Bollati V, Baccarelli A. Environmental epigenetics. Heredity (Edinb) 2010. 105:105-112. PMID:20179736. http://dx.doi.org/10.1038/hdy.2010.2.
12. Sharma S, Kelly TK, Jones PA. Epigenetics in cancer. Carcinogenesis 2010. 31:27-36. PMID:19752007. http://dx.doi.org/10.1093/carcin/bgp220.
13. Jensen TJ, Novak P, Wnek SM, Gandolfi AJ, Futscher BW. Arsenicals produce stable progressive changes in DNA methylation patterns that are linked to malignant transformation of immortalized urothelial cells. Toxicol Appl Pharmacol 2009. 241:221-229. PMID:19716837. http://dx.doi.org/10.1016/j.taap.2009.08.019.
14. Novak P, Jensen TJ, Garbe JC, Stampfer MR, Futscher BW. Stepwise DNA methylation changes are linked to escape from defined proliferation barriers and mammary epithelial cell immortalization. Cancer Res 2009. 69:5251-258. PMID:19509227. http://dx.doi.org/10.1158/0008-5472.CAN-08-4977.
15. Trojer P, Reinberg D. Facultative heterochromatin: is there a distinctive molecular signature? Mol Cell 2007. 28:1-13. PMID:17936700. http://dx.doi.org/10.1016/j.molcel.2007.09.011.
16. Frigola J, Song J, Stirzaker C, Hinshelwood RA, Peinado MA, Clark SJ. Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band. Nat Genet 2006. 38:540-549. PMID:16642018. http://dx.doi.org/10.1038/ng1781.
17. Stransky N, Vallot C, Reyal F, Bernard-Pierrot I, de Medina SG, Segraves R, et al. Regional copy numberindependent deregulation of transcription in cancer. Nat Genet 2006. 38:1386-1396. PMID:17099711. http://dx.doi.org/10.1038/ng1923.
18. Rauch T, Wang Z, Zhang X, Zhong X, Wu X, Lau SK, et al. Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarraybased methylated CpG island recovery assay. Proc Natl Acad Sci U S A 2007. 104:5527-5532. PMID:17369352. http://dx.doi.org/10.1073/pnas.0701059104.
19. Novak P, Jensen T, Oshiro MM, Watts GS, Kim CJ, Futscher BW. Agglomerative epigenetic aberrations are a common event in human breast cancer. Cancer Res 2008. 68:8616-8625. PMID:18922938. http://dx.doi.org/10.1158/0008-5472.CAN-08-1419.
20. Novak P, Jensen T, Oshiro MM, Wozniak RJ, Nouzova M, Watts GS, et al. Epigenetic inactivation of the HOXA gene cluster in breast cancer. Cancer Res 2006. 66:10664-10670. PMID:17090521. http://dx.doi.org/10.1158/0008-5472.CAN-06-2761.
21. Clark SJ. Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis. Hum Mol Genet 2007. 16(Spec No 1):R88-95. PMID:17613553. http://dx.doi.org/10.1093/hmg/ddm051.
22. Javierre BM, Rodriguez-Ubreva J, Al-Shahrour F, Corominas M, Graña O, Ciudad L, et al. Long-range epigenetic silencing associates with deregulation of Ikaros targets in colorectal cancer cells. Mol Cancer Res 2011. 9:1139-1151. PMID:21737484. http://dx.doi.org/10.1158/1541-7786.MCR-10-0515.
23. Dallosso AR, Hancock AL, Szemes M, Moorwood K, Chilukamarri L, Tsai HH, et al. Frequent long-range epigenetic silencing of protocadherin gene clusters on chromosome 5q31 in Wilms' tumor. PLoS Genet 2009. 5:e1000745. PMID:19956686. http://dx.doi.org/10.1371/journal.pgen.1000745.
24. Dallosso AR, Oster B, Greenhough A, Thorsen K, Curry TJ, Owen C, et al. Long-range epigenetic silencing of chromosome 5q31 protocadherins is involvedin early and late stages of colorectal tumorigenesis through modulation of oncogenic pathways. Oncogene 2012. PMID:22249255. http://dx.doi.org/10.1038/onc.2011.609.
25. Petzoldt JL, Leigh IM, Duffy PG, Sexton C, Masters JR. Immortalisation of human urothelial cells. Urol Res 1995. 23:377-380. PMID:8788275. http://dx.doi.org/10.1007/BF00698738.
26. Bello D, Webber MM, Kleinman HK, Wartinger DD, Rhim JS. Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18. Carcinogenesis 1997. 18:1215-1223. PMID:9214605. http://dx.doi.org/10.1093/carcin/18.6.1215.
27. Sommers SC, McManus RG. Multiple arsenical cancers of skin and internal organs. Cancer 1953. 6:347-359. PMID:13032927. http://dx.doi.org/10.1002/1097-0142(195303)6:2347::AIDCNCR28200602193.0.CO.2-L.
28. Chen CJ, Chen CW, Wu MM, Kuo TL. Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br J Cancer 1992. 66:888-892. PMID:1419632. http://dx.doi.org/10.1038/bjc.1992.380.
29. Benbrahim-Tallaa L, Waalkes MP. Inorganic arsenic and human prostate cancer. Environ Health Perspect 2008. 116:158-164. PMID:18288312. http://dx.doi.org/10.1289/ehp.10423.
30. Straif K, Benbrahim-Tallaa L, Baan R, Grosse Y, Secretan B, El Ghissassi F, et al. WHO International Agency for Research on Cancer Monograph Working Group. A review of human carcinogens--part C: metals, arsenic, dusts, and fibres. Lancet Oncol 2009. 10:453-454. PMID:19418618. http://dx.doi.org/10.1016/S1470-2045(09)70134-2.
31. Wnek SM, Jensen TJ, Severson PL, Futscher BW, Gandolfi AJ. Monomethylarsonous acid produces irreversible events resulting in malignant transformation of a human bladder cell line following 12 weeks of low-level exposure. Toxicol Sci 2010. 116:44-57. PMID:20375083. http://dx.doi.org/10.1093/toxsci/kfq106.
32. Benbrahim-Tallaa L, Webber MM, Waalkes MP. Acquisition of androgen independence by human prostate epithelial cells during arsenic-induced malignant transformation. Environ Health Perspect 2005. 113:1134-1139. PMID:16140617. http://dx.doi.org/10.1289/ehp.7832.
33. Jensen TJ, Wozniak RJ, Eblin KE, Wnek SM, Gandolfi AJ, Futscher BW. Epigenetic mediated transcriptional activation of WNT5A participates in arsenical-associated malignant transformation. Toxicol Appl Pharmacol 2009. 235:39-46. PMID:19061910. http://dx.doi.org/10.1016/j.taap.2008.10.013.
34. Jensen TJ, Novak P, Eblin KE, Gandolfi AJ, Futscher BW. Epigenetic remodeling during arsenicalinduced malignant transformation. Carcinogenesis 2008. 29:1500-1508. PMID:18448484. http://dx.doi.org/10.1093/carcin/bgn102
35. Benbrahim-Tallaa L, Waterland RA, Styblo M, Achanzar WE, Webber MM, Waalkes MP. Molecular events associated with arsenic-induced malignant transformation of human prostatic epithelial cells: aberrant genomic DNA methylation and K-ras oncogene activation. Toxicol Appl Pharmacol 2005. 206:288-298. PMID:16039940. http://dx.doi.org/10.1016/j.taap.2004.11.017.
36. Hansen KD, Timp W, Bravo HC, Sabunciyan S, Langmead B, McDonald OG, et al. Increased methylation variation in epigenetic domains across cancer types. Nat Genet 2011. 43:768-775. PMID:21706001. http://dx.doi.org/10.1038/ng.865.
37. Behn-Krappa A, Hölker I, Sandaradura de Silva U, Doerfler W. Patterns of DNA methylation are indistinguishable in different individuals over a wide range of human DNA sequences. Genomics 1991. 11:1-7. PMID:1722485. http://dx.doi.org/10.1016/0888-7543(91)90095-V.
38. Huschtscha LI, Noble JR, Neumann AA, Moy EL, Barry P, Melki JR, et al. Loss of p16INK4 expression by methylation is associated with lifespan extension of human mammary epithelial cells. Cancer Res 1998. 58:3508-3512. PMID:9721850.
39. Tzeng CC, Liu HS, Li C, Jin YT, Chen RM, Yang WH, et al. Characterization of two urothelium cancer cell lines derived from a blackfoot disease endemic area in Taiwan. Anticancer Res 1996. 16(4A):1797-804. PMID:8712703.
40. Wu X, Rauch TA, Zhong X, Bennett WP, Latif F, Krex D, et al. CpG island hypermethylation in human astrocytomas. Cancer Res 2010. 70:2718-2727. PMID:20233874. http://dx.doi.org/10.1158/0008-5472.CAN-09-3631.
41. Hawkins RD, Hon GC, Lee LK, Ngo Q, Lister R, Pelizzola M, et al. Distinct epigenomic landscapes of pluripotent and lineage-committed human cells. Cell Stem Cell 2010. 6:479-491. PMID:20452322. http://dx.doi.org/10.1016/j.stem.2010.03.018.
42. Ohm JE, McGarvey KM, Yu X, Cheng L, Schuebel KE, Cope L, et al. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet 2007. 39:237-242. PMID:17211412. http://dx.doi.org/10.1038/ng1972.
43. Schlesinger Y, Straussman R, Keshet I, Farkash S, Hecht M, Zimmerman J, et al. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet 2007. 39:232-236. PMID:17200670. http://dx.doi.org/10.1038/ng1950.
44. Epsztejn-Litman S, Feldman N, Abu-Remaileh M, Shufaro Y, Gerson A, Ueda J, et al. De novo DNA methylation promoted by G9a prevents reprogramming of embryonically silenced genes. Nat Struct Mol Biol 2008. 15:1176-1183. PMID:18953337. http://dx.doi.org/10.1038/nsmb.1476.
45. Lehnertz B, Ueda Y, Derijck AA, Braunschweig U, Perez-Burgos L, Kubicek S, et al. Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr Biol 2003. 13:1192-1200. PMID:12867029. http://dx.doi.org/10.1016/S0960-9822(03)00432-9.
46. Fuks F, Hurd PJ, Deplus R, Kouzarides T. The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase. Nucleic Acids Res 2003. 31:2305-2312. PMID:12711675. http://dx.doi.org/10.1093/nar/gkg332.
47. Coolen MW, Stirzaker C, Song JZ, Statham AL, Kassir Z, Moreno CS, et al. Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity. Nat Cell Biol 2010. 12:235-246. PMID:20173741.
48. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001. 414:105-111. PMID:11689955. http://dx.doi.org/10.1038/35102167.
49. Edwards JR, O'Donnell AH, Rollins RA, Peckham HE, Lee C, Milekic MH, et al. Chromatin and sequence features that define the fine and gross structure of genomic methylation patterns. Genome Res 2010. 20:972-980. PMID:20488932. http://dx.doi.org/10.1101/gr.101535.109.
50. Cheng YT, Li YL, Wu JD, Long SB, Tzai TS, Tzeng CC, et al. Overexpression of MDM-2 mRNA and mutation of the p53 tumor suppressor gene in bladder carcinoma cell lines. Mol Carcinog 1995. 13:173-181. PMID:7619220. http://dx.doi.org/10.1002/mc.2940130307.
51. Webber MM, Quader ST, Kleinman HK, Bello-DeOcampo D, Storto PD, Bice G, et al. Human cell lines as an in vitro/in vivo model for prostate carcinogenesis and progression. Prostate 2001. 47:1-13. PMID:11304724. http://dx.doi.org/10.1002/pros.1041.
52. Weber M, Davies JJ, Wittig D, Oakeley EJ, Haase M, Lam WL, et al. Chromosome-wide and promoterspecific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet 2005. 37:853-862. PMID:16007088. http://dx.doi.org/10.1038/ng1598.
53. Vrba L, Garbe JC, Stampfer MR, Futscher BW. Epigenetic regulation of normal human mammary cell type-specific miRNAs. Genome Res 2011. 21:2026-2037. PMID:21873453. http://dx.doi.org/10.1101/gr.123935.111.
54. R_Development_Core_Team. R: A language and environment for statistical computing. 2010.
55. Rossi MR, Masters JR, Park S, Todd JH, Garrett SH, Sens MA, et al. The immortalized UROtsa cell line as a potential cell culture model of human urothelium. Environ Health Perspect 2001. 109:801-808. PMID:11564615. http://dx.doi.org/10.1289/ehp.01109801.
56. Bredfeldt TG, Jagadish B, Eblin KE, Mash EA, Gandolfi AJ. Monomethylarsonous acid induces transformation of human bladder cells. Toxicol Appl Pharmacol 2006. 216:69-79. PMID:16806342. http://dx.doi.org/10.1016/j.taap.2006.04.011.
57. Achanzar WE, Webber MM, Waalkes MP. Altered apoptotic gene expression and acquired apoptotic resistance in cadmium-transformed human prostate epithelial cells. Prostate 2002. 52:236-244. PMID:12111698. http://dx.doi.org/10.1002/pros.10106.
58. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, et al. LNCaP model of human prostatic carcinoma. Cancer Res 1983. 43:1809-1818. PMID:6831420.
59. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 1979. 17:16-23. PMID:447482.
60. Stone KR, Mickey DD, Wunderli H, Mickey GH, Paulson DF. Isolation of a human prostate carcinoma cell line (DU 145). Int J Cancer 1978. 21:274-281. PMID:631930. http://dx.doi.org/10.1002/ijc.2910210305.